High Vista Strategies LLC Innoviva, Inc. Transaction History

High Vista Strategies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$8.11 - $15.23 $1.54 Million - $2.89 Million	-189,941 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$10.28 - $14.38 $6,168 - $8,628	-600 Reduced 0.31%	189,941 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$10.05 - $14.55 $6,030 - $8,730	600 Added 0.32%	190,541 $2.01 Million
Q2 2019 Aug 14, 2019	BUY	$13.1 - $14.95 $2.49 Million - $2.84 Million	189,941 New	189,941 $2.77 Million

229

79.2M

37.6K

300

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.33B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of High Vista Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on High Vista Strategies LLC with notifications on news.